Daytona Clinical Trial Site Now Enrolling for Heart Protection Study
Arrow has announced enrollment for a groundbreaking heart protection study evaluating inclisiran for preventing major adverse events from clogged arteries — including heart attack, stroke, and limb-threatening complications.
Arrow Clinical Trials, a physician-owned clinical research site based in Daytona Beach, has announced it is now enrolling participants for a groundbreaking heart protection study. The study evaluates the effectiveness of inclisiran, a medication already FDA approved for lowering cholesterol, for preventing major adverse events resulting from clogged arteries — including heart attack, stroke, or limb-threatening complications.
"This exciting study has the potential to prevent serious adverse events resulting from blocked arteries and, ultimately, save lives. We encourage individuals who either recently had an angioplasty procedure or plan to have one in the near future to consider participating or discuss this opportunity with their cardiologist."
— Dr. Charles Ross, Principal Investigator
Read the press release: PharmiWeb
Active Studies
See if you qualify for a current clinical trial.
Explore Arrow's active clinical trials and find opportunities to participate in cutting-edge research right here in Daytona Beach.
